High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1/2009 virus in mixed-virus- population samples

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3555-3559

  Lee, Hong Kai ^a,b   Lee, Chun Kiat ^a   Loh, Tze Ping ^a   Tang, Julian Wei Tze ^a   Tambyah, Paul Anantharajah ^b   Koay, Evelyn Siew Chuan ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; OSELTAMIVIR; TYROSINE;

2009 H1N1 INFLUENZA; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; GENE DOSAGE; GENETIC VARIABILITY; HIGH RESOLUTION MELTING ANALYSIS; HIGH THROUGHPUT SCREENING; INFLUENZA VIRUS A H1N1; MICROBIAL POPULATION DYNAMICS; MOLECULAR PROBE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE STUDY; SCREENING TEST; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERATURE SENSITIVITY; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE;

ANTIVIRAL AGENTS; COINFECTION; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTANT PROTEINS; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; SENSITIVITY AND SPECIFICITY; TRANSITION TEMPERATURE; VIRAL LOAD; VIRAL PROTEINS;

ORTHOMYXOVIRIDAE;

EID: 80053535579     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01087-11     Document Type: Article

References (27)

1. Baz, M., et al. 2009. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N. Engl. J. Med. 361:2296-2297.
2. Bennett, S., R. N. Gunson, A. MacLean, R. Miller, and W. F. Carman. 2011. The validation of a real-time RT-PCR assay which detects influenza A and types simultaneously for influenza A H1N1 (2009) and oseltamivir-resistant (H275Y) influenza A H1N1 (2009). J. Virol. Methods 171:86-90.
3. Centers for Disease Control and Prevention. 2008. Update: influenza activity - United States, September 28-November 29, 2008. MMWR Morb. Mortal. Wkly. Rep. 57:1329-1332.
4. Chen, W. J., et al. 2009. Rapid diagnosis of spinal muscular atrophy using high-resolution melting analysis. BMC Med. Genet. 10:45.
5. Chidlow, G. R., et al. 2010. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. J. Virol. Methods 169:47-51.
6. Dames, S., R. L. Margraf, D. C. Pattison, C. T. Wittwer, and K. V. Voelkerding. 2007. Characterization of aberrant melting peaks in unlabeled probe assays. J. Mol. Diagn. 9:290-296. (Pubitemid 47305064)
7. Dames, S., D. C. Pattison, L. K. Bromley, C. T. Wittwer, and K. V. Voelkerding. 2007. Unlabeled probes for the detection and typing of herpes simplex virus. Clin. Chem. 53:1847-1854. (Pubitemid 47509680)
8. De Jong, M. D., et al. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353:2667-2672. (Pubitemid 41817715)
9. Deyde, V. M., et al. 2009. Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrob. Agents Chemother. 53:1039-1047.
10. Dulek, D. E., et al. 2010. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin. Infect. Dis. 50:1493-1496.
11. Gaur, A. H., et al. 2010. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N. Engl. J. Med. 362:88-89.
12. Hindiyeh, M., et al. 2010. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR. J. Clin. Microbiol. 48:1884-1887.
13. Kramer, D., et al. 2009. A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations. Cell. Oncol. 31:161-167.
14. Lackenby, A., C. I. Thompson, and J. Democratis. 2008. The potential impact of neuraminidase inhibitor resistant influenza. Curr. Opin. Infect. Dis. 21:626-638.
15. Lee, H. K., et al. 2010. Diagnostic testing for pandemic influenza in Singapore: a novel dual-gene quantitative real-time RT-PCR for the detection of influenza A/H1N1/2009. J. Mol. Diagn. 12:636-643.
16. Memoli, M. J., R. J. Hrabal, A. Hassantoufighi, M. C. Eichelberger, and J. K. Taubenberger. 2010. Rapid selection of oseltamivir- and peramivirresistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin. Infect. Dis. 50:1252-1255.
17. Moore, C., et al. 2011. Evidence of person-to-person transmission of oseltamivir- resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J. Infect. Dis. 203:18-24.
18. Nukiwa, N., et al. 2010. Simplified screening method for detecting oseltamivir resistant pandemic influenza A (H1N1) 2009 virus by a RT-PCR/restriction fragment length polymorphism assay. J. Virol. Methods 170:165-168.
19. Renaud, C., J. Kuypers, and L. Corey. 2010. Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus. J. Clin. Virol. 49:21-25.
20. Sheu, T. G., et al. 2008. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52:3284-3292.
21. South Carolina Department of Health and Environmental Control. 10 July 2009, posting date. Three reports of oseltamivir resistant novel influenza A (H1N1) viruses. South Carolina Department of Health and Environmental Control, Columbia, SC. http://www.scdhec.gov/health/disease/han/docs /HAN-20090710-01. pdf.
22. Suhaila, M., et al. Mixtures of oseltamivir-sensitive and resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children. Pediatr. Infect. Dis. J. 30:625-627.
23. Tramontana, A. R., et al. 2010. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg. Infect. Dis. 16:1068-1075.
24. Trevino, C., S. Bihon, and B. A. Pinsky. 2011. A Synonymous change in the influenza A virus neuraminidase gene interferes with PCR-based subtyping and oseltamivir resistance mutation detection. J. Clin. Microbiol. 49:3101-3102. 25.
25. van der Stoep, N., et al. 2009. Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner. Hum. Mutat. 30:899-909.
26. Zhou, L., A. N. Myers, J. G. Vandersteen, L. Wang, and C. T. Wittwer. 2004. Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin. Chem. 50:1328-1335. (Pubitemid 38970639)
27. Zhou, L., L. Wang, R. Palais, R. Pryor, and C. T. Wittwer. 2005. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin. Chem. 51:1770-1777. (Pubitemid 41368166)